Delivery Order SPE2DR25D1106-SPE2DR26FJK5F
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,538.90 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of August 5, 2025. This is a firm fixed-price delivery order under a competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical supply vendor that serves military and veteran healthcare systems through the DLA...
- The Defense Logistics Agency awarded a delivery order valued at $3,034.01 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on December 19, 2025, with an ultimate completion date of December 22, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction supporting federal medical supply needs. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $2,355.81 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of December 30, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,326.27 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on January 28, 2026, with completion scheduled for January 29, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order contract valued at $18,016.80 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,356.33 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,564.63 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of November 5, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies medications, vaccines, medical devices, and...
- The Defense Logistics Agency awarded a delivery order valued at $16,817.04 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of January 6, 2026. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is listed as the vendor's corporate...
- The Defense Logistics Agency awarded a $31,839.65 delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on January 7, 2026, with a completion date of January 8, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,177.58 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on January 26, 2026, with an ultimate completion date of January 27, 2026. This non-competitive delivery order, structured as a firm fixed-price contract, will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems,...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJK5FDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,903.98 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on January 28, 2026, with an ultimate completion date of January 29, 2026. This is a firm fixed-price contract with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's medical supply chain. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. This comprehensive vehicle enables the contractor to supply a broad range of pharmaceutical products and medical supplies, including vaccines, specialty medications, brand-name and generic drugs, and other medical commodities to support military healthcare programs globally. The M-M-R II vaccine procurement reflects the contractor's ongoing role in delivering critical immunization products to federal government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 1/27/26 |